Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate ResMed Inc. before investing.

In this article, we go over a few key elements for understanding ResMed Inc.’s stock price such as:

• ResMed Inc.’s current stock price and volume
• Why ResMed Inc.’s stock price changed recently
• Upgrades and downgrades for RMD from analysts
• RMD’s stock price momentum as measured by its relative strength

About ResMed Inc. (RMD)

Before we jump into ResMed Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Want to learn more about ResMed Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about ResMed Inc..

ResMed Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, ResMed Inc.’s stock price was $210.980.

ResMed Inc. is up 1.16% from its previous closing price of $208.560.

During the last market session, ResMed Inc.’s stock traded between $205.220 and $211.780. Currently, there are approximately 145.34 million shares outstanding for ResMed Inc..

ResMed Inc.’s price-earnings (P/E) ratio is currently at 20.3, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

ResMed Inc. Stock Price History

ResMed Inc.’s (RMD) price is currently up 8.26% so far this month.

During the month of July, ResMed Inc.’s stock price has reached a high of $222.430 and a low of $190.210.

Over the last year, ResMed Inc. has hit prices as high as $293.810 and as low as $180.265. Year to date, ResMed Inc.’s stock is down 12.41%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused ResMed Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded ResMed Inc.’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate ResMed Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on ResMed Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

ResMed Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about ResMed Inc. (RMD) by visiting AAII Stock Evaluator.

Relative Price Strength of ResMed Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, ResMed Inc. has a weighted four-quarter relative price strength of -7.65%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how ResMed Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

ResMed Inc. Stock Price: Bottom Line

As of July 31, 2026, ResMed Inc.’s stock price is $210.980, which is up 1.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like ResMed Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.